Skip to content
Home/Companies/Pharma/Kent Pharmaceuticals
KP

Kent Pharmaceuticals

Pharma·UK·Active·7yr hold

Kent Pharmaceuticals is a pharma company, headquartered in UK.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Kent Pharmaceuticals?

Kent Pharmaceuticals is currently owned by Duke Street through DS Cornerstone Fund (2017 vintage), since 2019.

Hand-verified · updated 2026-05-29

Duke Street
Investor
Duke Street
DS Cornerstone Fund · 2017 · Buyout

Key facts

HQUK
SectorPharma
StatusActive

More from DS Cornerstone Fund

Other portfolio companies in the same fund.

McAvoy
Active
ConstructionUK· 2025
Agito Medical
Active
HealthTechDenmark· 2024
ForLife
Active
MedTechGermany· 2024
Suir Engineering
Active
IndustrialsIreland· 2022
COMPO
Active
ConsumerGermany· 2021
Great Rail Journeys
Exited 2025
HospitalityUK· 2018
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Forth Therapeutics
Active
Old College CapitalUK· 2025
THX Pharma
Active
Odyssée VentureFrance· 2025
Chanelle Pharma
Active
Exponent Private EquityIreland· 2024
Data refreshed weekly · Sourced from public filings